Credit Suisse analyst Tiago Fauth ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Wedbush Downgrades Apellis Pharmaceuticals (APLS) to NeutralSeptember 10, 2021 7:29 AM Apellis Pharmaceuticals (APLS) PT Lowered to $65 at OppenheimerSeptember 10, 2021 6:58 AM Apellis Pharmaceuticals (APLS) PT Lowered to $70 at Needham & CompanySeptember 10, 2021 6:54 AM Apellis Pharmaceuticals (APLS) PT Lowered to $69 at BMO Capital, Overall Data 'Should Still be Enough'September 10, 2021 6:40 AM